Melanoma

Melanoma is a form of cancer that begins in melanocytes (cells that make the pigment melanin). It may begin in a mole (skin melanoma), but can also begin in other pigmented tissues, such as in the eye or in the intestines.
What are Melanomas?

The treatment of melanoma may involve surgery, immunotherapy, targeted therapy, chemotherapy or radiotherapy, or a combination of several treatment techniques. Each of these treatments is outlined below.

Read More

Overview

Feature Articles

Latest Melanoma News and Research

Hannover and Rostock team up to develop non-invasive optical melanoma diagnostics

Hannover and Rostock team up to develop non-invasive optical melanoma diagnostics

PET/MRI reduces radiation exposure, improves lesion detectability in select cancers

PET/MRI reduces radiation exposure, improves lesion detectability in select cancers

Study uncovers new markers present on melanoma tumors

Study uncovers new markers present on melanoma tumors

Study provides insight into lymphomagenesis and patterns of resistance to immunotherapy

Study provides insight into lymphomagenesis and patterns of resistance to immunotherapy

UofL receives $11.5 million to accelerate the development of new immunotherapies

UofL receives $11.5 million to accelerate the development of new immunotherapies

Cell signaling research rings warning bells over an emerging cancer drug target

Cell signaling research rings warning bells over an emerging cancer drug target

New research reverses the understanding of kidney tumor growth

New research reverses the understanding of kidney tumor growth

New antitumor vaccines control melanoma growth in preclinical models

New antitumor vaccines control melanoma growth in preclinical models

Study sheds light on how interferon-gamma drives response to immunotherapy in melanoma

Study sheds light on how interferon-gamma drives response to immunotherapy in melanoma

DLnano-vaccines may be a promising strategy for cancer immunotherapy

DLnano-vaccines may be a promising strategy for cancer immunotherapy

Nanotechnological drug delivery system enhances the effectiveness of melanoma treatment

Nanotechnological drug delivery system enhances the effectiveness of melanoma treatment

Novel markers may predict patient response to immune checkpoint inhibitors

Novel markers may predict patient response to immune checkpoint inhibitors

Honeybee venom induces cancer cell death in aggressive breast cancer

Honeybee venom induces cancer cell death in aggressive breast cancer

Scientists identify key driver in BRAF inhibitor resistant melanoma

Scientists identify key driver in BRAF inhibitor resistant melanoma

Study: BIRC2 overexpression could be a key marker for immunotherapy resistance

Study: BIRC2 overexpression could be a key marker for immunotherapy resistance

Cancer cells reshape, destroy or integrate into blood vessels to spread

Cancer cells reshape, destroy or integrate into blood vessels to spread

Researchers discover how brain cancer cells evade the body's immune system

Researchers discover how brain cancer cells evade the body's immune system

First comparative data of encorafenib and paradox breaker inhibitors in BRAF mutant CRC

First comparative data of encorafenib and paradox breaker inhibitors in BRAF mutant CRC

New discovery about STING protein could lead to improved cancer immunotherapies

New discovery about STING protein could lead to improved cancer immunotherapies

Newly discovered molecule can suppress a wide range of cancers

Newly discovered molecule can suppress a wide range of cancers